elea | $4,351,562 | (Mar 13, 2025)
ATLANT 3D | $15,000,000 | (Mar 13, 2025)
Daupler | $15,000,000 | (Mar 13, 2025)
SAMABRIVA
France
- Amiens, Hauts-de-France
- 13/12/2023
- Unknown
- $4,313,000
Samabriva Biotechnology is a company that is creating a new method for producing biopharmaceuticals, chemicals, and biotech products using plants. Samabriva’s flexible platform combines the benefits of plant-based systems and traditional biomanufacturing techniques. By developing and cultivating high-yield plant clones in large-scale bioreactors it is possible to produce large quantities of high-value products more efficiently than traditional manufacturing methods.
- Industry Biotechnology Research
- Website https://samabriva.com/
- LinkedIn https://www.linkedin.com/company/samabriva/about/
Related People
Marina GuilletFounder
France -
Greater Nantes Metropolitan Area
Samabriva Biotechnology is a company that is creating a new method for producing biopharmaceuticals, chemicals, and biotech products using plants. Samabriva’s flexible platform combines the benefits of plant-based systems and traditional biomanufacturing techniques. By developing and cultivating high-yield plant clones in large-scale bioreactors it is possible to produce large quantities of high-value products more efficiently than traditional manufacturing methods.
WATTER | $5,000,000 | (Mar 13, 2025)
QuamCore | $9,000,000 | (Mar 13, 2025)
Hawcx | $3,000,000 | (Mar 13, 2025)
LlamaIndex | $19,000,000 | (Mar 13, 2025)
Carpool Logistics | $12,000,000 | (Mar 13, 2025)
Quanta | $4,700,000 | (Mar 13, 2025)
Nervonik, Inc. | $13,000,000 | (Mar 13, 2025)
Odeko | $126,000,000 | (Mar 13, 2025)
MaxIQ | $7,800,000 | (Mar 13, 2025)